The Auckland Bioengineering Institute is pioneering the development of mathematical models of human physiology and new instrumentation techniques for a wide variety of healthcare applications

The ABI's vision is to provide virtual human models which can be personalized and used, with new medical devices, as the basis for improved and lower cost 21st century healthcare

Auckland Bioengineering Institute

The ABI has strong research links with the Faculties of Engineering, Science, and Medical and Health Sciences. A very close relationship is maintained with the Department of Engineering Science, particularly through involvement in the BE(Hons) in Biomedical Engineering degree program.

The institute has around 150 members, of which more than 60 are graduate students enrolled in Doctoral or Masters research. All our students are members of at least one multi-disciplinary research team, which often include valuable collaborations with domestic and international clinicians, medical professionals, computer scientists and bioengineers.

Collaborators

Baker Heart Institute
Biomouth Research Group
Cedars-Sinai Cardiology
Indiana University
Massachusetts Institute of Technology
Massey University
Mayo Clinic
Mercy Angiography Unit
National University of Singapore
Sherbrooke University
Siemens
Sydney Melanoma Unit
Telemetry Research Ltd
The Hatter Institute
University of Bristol
University of California Los Angeles

University of California San Diego
University of Canterbury
University of Iowa
University of Leipzig
University of Nevada
University of Otago
University of Oxford
University of Sheffield
University of Stuttgart
University of Texas
University of Virginia
University of Washington
Vanderbilt University
Varian
Wellcome Trust

About

Principal

Peter Hunter

"Personalized modeling of joints, using multi scale bioengineering approaches, offers a powerful tool for diagnostics, therapeutics and implant design. The Auckland Bioengineering Institute is delighted to be contributing to clinical applications in musculo-skeletal biomechanics through its research partnership with eBonz Ltd. I am confident that our ability to link structure and function at the level of muscles, bones, cartilage, etc, to the metabolic, regulatory and signaling pathways underlying cell and tissue function will assist greatly in improving the design of medical devices and in diagnostic and therapeutic strategies in the clinic."

Peter Hunter, FRS.